Pharmacology and Pharmaceutical Sciences articles for Fudan University, China

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 46

Article ‘Count’ for Pharmacology and Pharmaceutical Sciences.

Journal Count Share
4 2.08
Deciphering Apolipoprotein A4 in the Protein Corona of Ligand-Modified Liposomes for Tumor Targeting and Penetration 0.50
Solvation-Layer Mediated Interfacial Assembly for Surface Topological Engineering of Mesoporous Microcarriers 0.80
Near-Infrared Light-Triggered In Situ Construction of 3D “Fishing Net” Polymer Networks Using Upconversion Nanoparticles for Tumor Therapy 0.11
Inflammatory Macrophage-Targeted Atherosclerosis Treatment by miRNA-Delivered, MRI-Visible, and Anti-Inflammatory Nanomedicine 0.67
2 1.80
Sulfhydryl-modified nanocarriers enhance corneal retention and ocular anti-inflammatory efficacy in dry eye therapy 0.80
Toward preclinical evaluation of a thermosensitive PEG-poly(L-alanine) hydrogel: A study on sterilization, storage stability, and in vivo performance 1.00
4 1.62
A Multifunctional NIR‐II Rare‐Earth Nanoagent for In Vivo Monitoring Cancer Revascularization and Prognosis 0.37
Sono-Controllable Janus Microneedle for Postsurgical Tumor Eradication and Scarless Wound Healing in Melanoma 0.31
Overcoming Solubility Limitations in Inverse Temperature Crystallization for Universal Growth of High‐Quality Perovskite Single Crystals for X‐Ray Detection 0.89
Four‐Pronged Nanomotor Strategy Achieves Efficient TNBC Treatment via Synergistic Chemo‐Photothermal‐Immune Therapy 0.05
2 1.73
Engineered‐Macrophage‐Escorted Rotaxane Nanoscavengers for Precise Diquat Detoxification 0.91
Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer 0.83
1 1.00
In Situ Characterization and Deep Profiling of Engineered Multispecific Nanoparticle Metabolite Coronas for Precise Serum Diagnostics 1.00
3 0.46
Programmable Coacervate–Membrane Interactions Direct Internal and Collective Organization in Membranized Protocells 0.13
Reverse Lipid Droplet Function for Hepatocellular Carcinoma Immunotherapy 0.29
De Novo Design of Hexamer‐Linker Dual‐Action Nano‐PROTAC for Tumor‐Specific Ferroptosis 0.05
1 0.82
Hijacking ERAD for targeted degradation of transmembrane proteins 0.82
2 0.39
HFIP-Promoted [18F] trifluoromethylation via iodofluorination of gem-difluoroalkenes 0.25
A trident-like multi-cationic photosensitizer with stabilized membrane camouflage for efficient tumor-targeted photodynamic therapy 0.14
1 0.53
Predictors, Sources, and Health Risks of Environmental Antibiotic Exposure in Chinese Pregnant Women 0.53
3 1.30
Prenatal exposure to metal(loid)s and hormone profile in umbilical cord serum: Evidence of sex-specific association 0.94
First-Trimester Profiling of Maternal Plasma Metals and Vitamins in Relation to Gestational Hypertension 0.31
Prenatal exposure to environmental metal mixtures and social development in early childhood: Evidence from a birth cohort and mechanistic study 0.06
3 1.94
Classification Pretraining Enhances Performance of Target-Based Affinity Prediction for Reproductive Toxicity Assessment 0.70
Structure-Informed Comprehensive Screening and Risk Prioritization of Organophosphorus Compounds in Human Serum: Revealing the Hidden Burden and Emerging Risks 0.58
ChemBioHepatox: Multimodal Integrating Chemical Structure and Biological Fingerprint for Robust and Interpretable Hepatotoxicity Prediction 0.67
1 0.74
GLP-1R agonists and heart failure: novel beneficial effects suggested by Mendelian randomization 0.74
5 1.46
In Situ Transformable Photothermal Targeting Chimeras for Spatiotemporally Controllable Protein Degradation and Combination Immunotherapy for Cancer 0.08
Biocatalytic- and Chemoproteomic-Guided Discovery of a PHGDH Inhibitor from Chemoenzymatic-Promoted DNA-Encoded Libraries Selection Platform 0.15
Pretargeted Mitochondrial Delivery of Organoarsenicals for Cancer Immunotherapy 0.22
Trotline-Inspired Mesoporous Carriers for Prolonged Gastrointestinal Retention 0.82
Zwitterionic Sulfadiazine-Based Micelle Achieves Effective Drug Delivery to Glioblastoma by Overcoming Multiple Biological Barriers 0.20
3 0.19
Synergistic Chemoimmunotherapy of Hepatocellular Carcinoma via ROS-Responsive Carrier-Free Prodrug Nanoparticles 0.02
Carbonic Anhydrase Targeting Polymer with Enhanced Intracellular Protein Delivery and Tumor Penetration for Cancer Therapy 0.05
A Synthetic Liposome Nanoparticle Vaccine Platform for Broad-Spectrum Vaccine Design 0.13
1 0.03
Language model-guided anticipation and discovery of mammalian metabolites 0.03
5 1.87
Structural evolution of carbon frameworks realizes in vitro interfacial transport in metabolically reprogrammed senescent cells for senolysis 0.07
XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures 0.07
Molecular basis of prostaglandin E reuptake by organic anion transporter PGT 0.67
Molecular mechanisms of SLC30A10-mediated manganese transport 1.00
Two-dimensional superlattice nanocatalysts unlock multimodal energy transformation-driven catalytic therapy 0.06
1 0.33
Pyridine-Fused C25 abeo-Steroid Alkaloids from a Fungus: Biomimetic Semisynthesis and Anti-HIV Mechanistic Study 0.33
2 0.33
Loss of vitamin C biosynthesis protects from the pathology of a parasitic infection 0.27
Manifold-constrained nucleus-level denoising diffusion model for structure-based drug design 0.06
1 0.06
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial 0.06
1 0.01
Screening toxic transformation products of emerging pollutants in advanced oxidation processes with 3D deep learning and in vitro assays 0.01

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.